Postsurgical wound infections due to rapidly growing mycobacteria in Swiss medical tourists following cosmetic surgery in Latin America between 2012 and 2014

Eurosurveillance

Volumn 19, Issue 37, 2014, Pages

  Maurer, F P ^a   Castelberg, C ^a   Braun Von, A ^b   Wolfensberger, A ^b   Bloemberg, G V ^a   Bottger E C ^a   Somoskovi, A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; LINEZOLID; MOXIFLOXACIN; OXYTETRACYCLINE; TIGECYCLINE;

ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BREAST AUGMENTATION; BREAST REDUCTION; CLINICAL ARTICLE; DEBRIDEMENT; DRUG SENSITIVITY; ESTHETIC SURGERY; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPOSUCTION; MEDICAL TOURISM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM MASSILIENSE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SKIN DEFECT; SOUTH AND CENTRAL AMERICA; SURGICAL INFECTION; SWISS;

EID: 84907743359     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.37.20905     Document Type: Article

References (33)

1. Adekambi T, Stein A, Carvajal J, Raoult D, Drancourt M. Description of Mycobacterium conceptionense sp. nov., a Mycobacterium fortuitum group organism isolated from a posttraumatic osteitis inflammation. J Clin Microbiol. 2006;44(4):1268-73. http://dx.doi.org/10.1128/ JCM.44.4.1268-1273.2006
2. Whipps CM, Butler WR, Pourahmad F, Watral VG, Kent ML. Molecular systematics support the revival of Mycobacterium salmoniphilum (ex Ross 1960) sp. nov., nom. rev., a species closely related to Mycobacterium chelonae. Int J Syst Evol Microbiol. 2007;57(Pt 11):2525-31. http://dx.doi.org/10.1099/ ijs.0.64841-0
3. Clinical and Laboratory Standards Institute (CLSI). Susceptibility testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard-Second Edition. CLSI document M24-A2. Wayne: CLSI; 2011.
4. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367-76. http://dx.doi.org/10.1128/AAC.01275-08
5. Macheras E, Konjek J, Roux AL, Thiberge JM, Bastian S, Leão SC, et al. Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Res Microbiol. 2014;165(2):82-90. http://dx.doi.org/10.1016/j. resmic.2013.12.003
6. Zhang Y, Rajagopalan M, Brown BA, Wallace RJ Jr. Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol. 1997;35(12):3132-9.
7. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42(12):1756-63. http:// dx.doi.org/10.1086/504381
8. Foz A, Roy C, Jurado J, Arteaga E, Ruiz JM, Moragas A. Mycobacterium chelonei iatrogenic infections. J Clin Microbiol. 1978;7(3):319-21.
9. Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987;317(4):197-201. http://dx.doi.org/10.1056/NEJM198707233170403
10. Villanueva A, Calderon RV, Vargas BA, Ruiz F, Aguero S, Zhang Y, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis. 1997;24(6):1147-53. http://dx.doi. org/10.1086/513656
11. Thomson R, Tolson C, Sidjabat H, Huygens F, Hargreaves M. Mycobacterium abscessus isolated from municipal water - a potential source of human infection. BMC Infect Dis. 2013;13:241. http://dx.doi.org/10.1186/1471-2334-13-241
12. Covert TC, Rodgers MR, Reyes AL, Stelma GN Jr. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol. 1999;65(6):2492-6.
13. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416. http://dx.doi.org/10.1164/rccm.200604-571ST
14. Bechara C, Macheras E, Heym B, Pages A, Auffret N. Mycobacterium abscessus skin infection after tattooing: first case report and review of the literature. Dermatology. 2010;221(1):1-4. http://dx.doi.org/10.1159/000313974
15. Wallace RJ Jr., Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5(4):657-79. http://dx.doi. org/10.1093/clinids/5.4.657
16. Villanueva A, Calderon RV, Vargas BA, Ruiz F, Aguero S, Zhang Y, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis. 1997;24(6):1147-53. http://dx.doi. org/10.1086/513656
17. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15(4):716-46. http:// dx.doi.org/10.1128/CMR.15.4.716-746.2002
18. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012;67(4):810-8. http://dx.doi. org/10.1093/jac/dkr578.
19. Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25(3):545-82. http://dx.doi.org/10.1128/ CMR.05030-11
20. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52(5):565-71. http://dx.doi.org/10.1093/ cid/ciq237
21. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180(9):896-902. http://dx.doi.org/10.1164/ rccm.200905-0704OC
22. Maurer FP, Ruegger V, Ritter C, Bloemberg GV, Böttger EC. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). J Antimicrob Chemother. 2012;67(11):2606-11. http://dx.doi.org/10.1093/jac/dks279
23. Wallace RJ Jr., Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996;40(7):1676-81.
24. Böttger EC. Transmission of M. abscessus in patients with cystic fibrosis. Lancet. 2013;382(9891):503-4. http://dx.doi. org/10.1016/S0140-6736(13)61708-0
25. Thibeaut S, Levy PY, Pelletier ML, Drancourt M. Mycobacterium conceptionense infection after breast implant surgery, France. Emerg Infect Dis. 2010;16(7):1180-1. http://dx.doi.org/10.3201/eid1607.090771
26. Sampaio JL, Chimara E, Ferrazoli L, da Silva Telles MA, Del Guercio VM, Jericó ZV, et al. Application of four molecular typing methods for analysis of Mycobacterium fortuitum group strains causing post-mammaplasty infections. Clin Microbiol Infect. 2006;12(2):142-9. http://dx.doi. org/10.1111/j.1469-0691.2005.01312.x
27. Winthrop KL, Abrams M, Yakrus M, Schwartz I, Ely J, Gillies D, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med. 2002;346(18):1366-71. http://dx.doi.org/10.1056/NEJMoa012643 28.
28. Wallace RJ Jr., Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985;152(3):500-14. http://dx.doi. org/10.1093/infdis/152.3.500
29. Furuya EY, Paez A, Srinivasan A, Cooksey R, Augenbraun M, Baron M, et al. Outbreak of Mycobacterium abscessus wound infections among “lipotourists” from the United States who underwent abdominoplasty in the Dominican Republic. Clin Infect Dis. 2008;46(8):1181-8. http://dx.doi. org/10.1086/529191
30. Centers for Disease Control and Prevention. Nontuberculous mycobacterial infections after cosmetic surgery—Santo Domingo, Dominican Republic, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004;53(23):509.
31. Newman MI, Camberos AE, Ascherman J. Mycobacteria abscessus outbreak in US patients linked to offshore surgicenter. Ann Plast Surg. 2005;55(1):107-10; discussion 10. http://dx.doi.org/10.1097/01.sap.0000168030.87804.93
32. Viana-Niero C, Lima KV, Lopes ML, Rabello MC, Marsola LR, Brilhante VC, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol. 2008;46(3):850-5. http://dx.doi.org/10.1128/ JCM.02052-07
33. Schnabel D, Gaines J, Nguyen DB, Esposito DH, Ridpath A, Yacisin K, et al. Notes from the field: rapidly growing nontuberculous Mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic--multiple states, March 2013-February 2014. MMWR Morb Mortal Wkly Rep. 2014;63(9):201-2.